A study showed that curcumin could also down-regulate glycolytic-related factors HIF-1α, LDHA, MCT1 and MDR1, STAT3 gene expression in liver cancer cells, resulting in the elevation of micro-enviromental pH to combat lactate-induced drug resistance to doxorubicin (Soni et al., 2020). This evidence concerns the gene LDHA and liver cancer.